Invesco’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,893
| Closed | -$186K | – | 4134 |
|
|
2021
Q4 | $186K | Sell |
3,893
-253
| -6% | -$17.4K | ﹤0.01% | 3802 |
|
|
2021
Q3 | $381K | Buy |
4,146
+146
| +4% | +$12.1K | ﹤0.01% | 3549 |
|
|
2021
Q2 | $382K | Sell |
4,000
-34
| -0.8% | -$2.97K | ﹤0.01% | 3532 |
|
|
2021
Q1 | $393K | Sell |
4,034
-544
| -12% | -$66.8K | ﹤0.01% | 3442 |
|
|
2020
Q4 | $379K | Sell |
4,578
-198
| -4% | -$18.2K | ﹤0.01% | 3317 |
|
|
2020
Q3 | $295K | Sell |
4,776
-157
| -3% | -$11.8K | ﹤0.01% | 3328 |
|
|
2020
Q2 | $435K | Sell |
4,933
-3,269
| -40% | -$346K | ﹤0.01% | 3196 |
|
|
2020
Q1 | $918K | Buy |
8,202
+4,677
| +133% | +$921K | ﹤0.01% | 2767 |
|
|
2019
Q4 | $863K | Buy |
3,525
+491
| +16% | +$124K | ﹤0.01% | 3064 |
|
|
2019
Q3 | $1.04M | Buy |
3,034
+247
| +9% | +$134K | ﹤0.01% | 2979 |
|
|
2019
Q2 | $2.56M | Sell |
2,787
-598
| -18% | -$735K | ﹤0.01% | 2567 |
|
|
2019
Q1 | $5.4M | Sell |
3,385
-9,507
| -74% | -$17.1M | ﹤0.01% | 1961 |
|
|
2018
Q4 | $24.1M | Buy |
12,892
+257
| +2% | +$559K | 0.01% | 1063 |
|
|
2018
Q3 | $29.8M | Buy |
12,635
+1,726
| +16% | +$5.34M | 0.01% | 1059 |
|
|
2018
Q2 | $37.6M | Buy |
10,909
+8,868
| +434% | +$27.2M | 0.01% | 951 |
|
|
2018
Q1 | $5.79M | Sell |
2,041
-8,871
| -81% | -$26.6M | ﹤0.01% | 1858 |
|
|
2017
Q4 | $28.1M | Buy |
10,912
+360
| +3% | +$1.02M | 0.01% | 1029 |
|
|
2017
Q3 | $29.9M | Buy |
10,552
+5,838
| +124% | +$15.4M | 0.01% | 993 |
|
|
2017
Q2 | $11.1M | Buy |
4,714
+1,315
| +39% | +$2.61M | ﹤0.01% | 1488 |
|
|
2017
Q1 | $8.56M | Buy |
3,399
+2,320
| +215% | +$6.68M | ﹤0.01% | 1643 |
|
|
2016
Q4 | $2.44M | Sell |
1,079
-2,433
| -69% | -$5.78M | ﹤0.01% | 2445 |
|
|
2016
Q3 | $8.8M | Buy |
3,512
+191
| +6% | +$570K | ﹤0.01% | 1583 |
|
|
2016
Q2 | $10.2M | Buy |
3,321
+395
| +13% | +$1.28M | ﹤0.01% | 1430 |
|
|
2016
Q1 | $9.29M | Sell |
2,926
-909
| -24% | -$3.77M | ﹤0.01% | 1470 |
|
|
2015
Q4 | $19.7M | Sell |
3,835
-916
| -19% | -$4M | 0.01% | 1158 |
|
|
2015
Q3 | $15.1M | Sell |
4,751
-423
| -8% | -$1.64M | 0.01% | 1265 |
|
|
2015
Q2 | $20.7M | Buy |
5,174
+434
| +9% | +$1.68M | 0.01% | 1202 |
|
|
2015
Q1 | $18.9M | Buy |
4,740
+797
| +20% | +$3.65M | 0.01% | 1215 |
|
|
2014
Q4 | $19.3M | Sell |
3,943
-2
| -0.1% | -$8.58K | 0.01% | 1187 |
|
|
2014
Q3 | $16M | Sell |
3,945
-3,142
| -44% | -$11.8M | 0.01% | 1280 |
|
|
2014
Q2 | $28.7M | Sell |
7,087
-3,350
| -32% | -$13.7M | 0.01% | 1061 |
|
|
2014
Q1 | $47.5M | Sell |
10,437
-1,986
| -16% | -$8.03M | 0.02% | 807 |
|
|
2013
Q4 | $43.5M | Sell |
12,423
-39
| -0.3% | -$152K | 0.02% | 863 |
|
|
2013
Q3 | $51.1M | Buy |
12,462
+278
| +2% | +$1.2M | 0.02% | 759 |
|
|
2013
Q2 | $48.2M | Buy |
+12,184
| New | +$50.2M | 0.02% | 728 |
|
Other funds holding ACOR
CCA
BCM
Invesco's ACOR Position: Q1 2022 in Review
Invesco sold out of Acorda Therapeutics (ACOR) in Q1 2022, closing a stake of 3,893 shares — an estimated $186K sold.
Invesco first reported a position in ACOR in Q2 2013 and held it in 35 quarters. The position peaked at $51.1M in Q3 2013. 31 funds tracked by Wall St. Rank hold ACOR as of Q1 2022.
- Invesco reported no remaining Acorda Therapeutics position as of Q1 2022 after selling out during the quarter.
- Invesco sold 3,893 Acorda Therapeutics shares in Q1 2022, an estimated $186K.
- Invesco first reported a position in Acorda Therapeutics in Q2 2013 and held it in 35 quarters.
- Invesco's Acorda Therapeutics position peaked at $51.1M in Q3 2013.
- 31 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2022.
Based on Invesco's 13F filing for Q1 2022, filed 16 May 2022.